Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone plus sildenafil versus placebo for attention, valence, and sexual arousal in women with and without female sexual dysfunction
NL-OMON20791Active, not recruiting
- Sponsor
- Emotional Brain
- Start
- Jun 1978
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of testosterone and sildenafil in female sexual dysfunction (FSD), hypoactive sexual desire disorder (HSDD) and Sexual Arousal Disorder (2 arms), sponsored by Emotional Brain. Primary endpoints: Attention for erotic stimuli, Vaginal pulse amplitude and 1 more. Started Jun 1978; status: active, not recruiting.
02
Drugs
testosteronesildenafil
03
Conditions
female sexual dysfunction (FSD)hypoactive sexual desire disorder (HSDD)Sexual Arousal Disorder
Beyond the preview
Go deeper on NL-OMON20791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20791.